Children’s Exposure to emerging Bisphenols other than Bisphenol A: It’s time for more biomonitoring studies
Davide Staedler
Abstract
Open-access reader
Davide Staedler
Abstract
Open-access reader
There is a great deal of evidence which has raised the need for various governmental organizations to regulate the use of bisphenol A (BPA) as plasticizer [1-4]. Indeed, BPA has shown endocrine disruptor effects, associated with a wide range of health outcomes [5,6]. Furthermore, biomonitoring investigations have frequently detected the presence of BPA in human urine, serum and breast milk; therefore, the exposure to this substance has been reported to be widespread [7-9].
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
There is a great deal of evidence which has raised the need for various governmental organizations to regulate the use of bisphenol A (BPA) as plasticizer [1-4]. Indeed, BPA has shown endocrine disruptor effects, associated with a wide range of health outcomes [5,6]. Furthermore, biomonitoring investigations have frequently detected the presence of BPA in human urine, serum and breast milk; therefore, the exposure to this substance has been reported to be widespread [7-9].
Key concepts: Biomonitoring, Endocrine disruptor, Bisphenol A, Bisphenol S, Endocrine system, Xenoestrogen, Bisphenol, Environmental health